300 related articles for article (PubMed ID: 25677875)
1. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Kak M; Nanda R; Ramsdale EE; Lukas RV
J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
[TBL] [Abstract][Full Text] [Related]
2. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal metastasis from systemic cancer: Review and update on management.
Wang N; Bertalan MS; Brastianos PK
Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
[TBL] [Abstract][Full Text] [Related]
4. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
[TBL] [Abstract][Full Text] [Related]
5. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
6. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
10. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal metastasis from systemic cancer.
Clarke JL
Continuum (Minneap Minn); 2012 Apr; 18(2):328-42. PubMed ID: 22810130
[TBL] [Abstract][Full Text] [Related]
12. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM).
Niwińska A; Pogoda K; Michalski W; Kunkiel M; Jagiełło-Gruszfeld A
J Neurooncol; 2018 May; 138(1):191-198. PubMed ID: 29435818
[TBL] [Abstract][Full Text] [Related]
13. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
14. Management of leptomeningeal metastases in non-small cell lung cancer.
Patil S; Rathnum KK
Indian J Cancer; 2019 Nov; 56(Supplement):S1-S9. PubMed ID: 31793437
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal metastases: the future is now.
Lukas RV; Thakkar JP; Cristofanilli M; Chandra S; Sosman JA; Patel JD; Kumthekar P; Stupp R; Lesniak MS
J Neurooncol; 2022 Feb; 156(3):443-452. PubMed ID: 35048267
[TBL] [Abstract][Full Text] [Related]
16. Treatment Options for Leptomeningeal Metastases of Solid Cancers: Literature Review and Personal Experience.
Kondoh T; Sonoda T
Acta Neurochir Suppl; 2021; 128():71-84. PubMed ID: 34191063
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures.
Kusumoto T; Kimura Y; Sugiyama M; Ohta M; Tsutsumi N; Sakaguchi Y; Ikejiri K; Oki E; Saeki H; Morita M; Ikeda T; Furuta T; Maehara Y
Fukuoka Igaku Zasshi; 2013 Nov; 104(11):456-63. PubMed ID: 24620642
[TBL] [Abstract][Full Text] [Related]
18. High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature.
Kapke JT; Schneidewend RJ; Jawa ZA; Huang CC; Connelly JM; Chitambar CR
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):189-193. PubMed ID: 31629723
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal metastasis in breast cancer - a systematic review.
Scott BJ; Oberheim-Bush NA; Kesari S
Oncotarget; 2016 Jan; 7(4):3740-7. PubMed ID: 26543235
[TBL] [Abstract][Full Text] [Related]
20. New strategies for the treatment of breast cancer with leptomeningeal metastasis.
Chew SM; Seidman AD
Curr Opin Oncol; 2023 Nov; 35(6):500-506. PubMed ID: 37820086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
